Advances in targeted cancer therapy:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basel [u.a.]
Birkhäuser
2005
|
| Schriftenreihe: | Progress in drug research
63 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | VII, 303 S. Ill., graph. Darst. |
| ISBN: | 3764371749 9783764371746 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV020049989 | ||
| 003 | DE-604 | ||
| 005 | 20070117 | ||
| 007 | t | ||
| 008 | 050929s2005 ad|| |||| 00||| eng d | ||
| 020 | |a 3764371749 |9 3-7643-7174-9 | ||
| 020 | |a 9783764371746 |9 978-3-7643-7174-6 | ||
| 035 | |a (OCoLC)61765779 | ||
| 035 | |a (DE-599)BVBBV020049989 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 | ||
| 050 | 0 | |a RC271.C5 | |
| 082 | 0 | |a 616.99/4061 |2 22 | |
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Advances in targeted cancer therapy |c ed. by Richard M. Schultz |
| 264 | 1 | |a Basel [u.a.] |b Birkhäuser |c 2005 | |
| 300 | |a VII, 303 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Progress in drug research |v 63 | |
| 650 | 7 | |a Chemotherapie |2 swd | |
| 650 | 7 | |a Krebs <Medizin> |2 swd | |
| 650 | 4 | |a Antineoplastic Agents |x therapeutic use | |
| 650 | 4 | |a Cancer |x Chemotherapy | |
| 650 | 4 | |a Drug Delivery Systems | |
| 650 | 4 | |a Drug targeting | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 700 | 1 | |a Schultz, Richard M. |e Sonstige |0 (DE-588)130400289 |4 oth | |
| 830 | 0 | |a Progress in drug research |v 63 |w (DE-604)BV002528909 |9 63 | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013370934 | ||
Datensatz im Suchindex
| _version_ | 1804133626161397760 |
|---|---|
| adam_text | Contents
Foreword
Dawn of a new era in molecular cancer therapeutics
Richard M.
Obstacles and opportunities in the clinical development
of targeted therapeutics
Grace K. Dy and Alex A. Adjei
Tumor models for preclinical development of targeted agents
Beverly A. Teicher
Angiogenesis inhibitors: what is the clinical future?
Henk M.W.
Epidermal growth factor receptor (EGFR) inhibitors
in cancer therapy
Fortunato Ciardiello
Cell survival signaling during apoptosis: Implications in drug
resistance and anti-cancer therapeutic development
Grace Choy, Jun-Wei Liu, Dhyan Chandra and Dean G. Tang
Targeted histone deacetylase inhibition for cancer prevention
and therapy
Carlo
Inhibitors of cyclin-dependent kinase modulators
for cancer therapy
Adrian M. Senderowicz
Targeting cyclooxygenase-Z for cancer prevention and treatment
Stephen T. Gately
v
Antisense
Elizabeth Rayburn, Wei Wang, Ruiwen Zhang and
Preclinical development of Alimta (Pemetrexed, LY231514),
a multitargeted
Richard M.
Index
vi
There have been tremendous advances in our understanding
of molecular and tumor biology during the past few years. In
the field of cancer therapeutics, it is expected that cytotoxic
drug approaches will be gradually replaced with treatments
based on biological targeted approaches. Hopefully these new
targeted therapies will significantly increase efficacy and lack
the devastating and troublesome side effects elicited by
cytotoxic chemotherapy.
This volume is the first book to cover the general topic of
targeted cancer therapy. It presents a range of targets such as
tumor angiogenesis, cell cycle control and cell signalling,
COX-2, apoptosis/cell survival and approaches like kinase
inhibitors, antisense, and antibody-based therapeutics. The
emphasis is on preclinical development, including target
validation, development of biomarkers, strategies for combi¬
nation approaches, and development of resistance. The par¬
ticular challenges involved in translating these data to clinical
application are discussed. This volume should be of broad
general interest to researchers and clinicians involved in cancer
therapy as well as other scientists interested in current
strategies for cancer treatment.
|
| any_adam_object | 1 |
| author_GND | (DE-588)130400289 |
| building | Verbundindex |
| bvnumber | BV020049989 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 3200 |
| ctrlnum | (OCoLC)61765779 (DE-599)BVBBV020049989 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01805nam a2200433 cb4500</leader><controlfield tag="001">BV020049989</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070117 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050929s2005 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3764371749</subfield><subfield code="9">3-7643-7174-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783764371746</subfield><subfield code="9">978-3-7643-7174-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)61765779</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV020049989</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advances in targeted cancer therapy</subfield><subfield code="c">ed. by Richard M. Schultz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel [u.a.]</subfield><subfield code="b">Birkhäuser</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VII, 303 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Progress in drug research</subfield><subfield code="v">63</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Krebs <Medizin></subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug targeting</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schultz, Richard M.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)130400289</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Progress in drug research</subfield><subfield code="v">63</subfield><subfield code="w">(DE-604)BV002528909</subfield><subfield code="9">63</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013370934</subfield></datafield></record></collection> |
| id | DE-604.BV020049989 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:11:42Z |
| institution | BVB |
| isbn | 3764371749 9783764371746 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013370934 |
| oclc_num | 61765779 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | VII, 303 S. Ill., graph. Darst. |
| publishDate | 2005 |
| publishDateSearch | 2005 |
| publishDateSort | 2005 |
| publisher | Birkhäuser |
| record_format | marc |
| series | Progress in drug research |
| series2 | Progress in drug research |
| spelling | Advances in targeted cancer therapy ed. by Richard M. Schultz Basel [u.a.] Birkhäuser 2005 VII, 303 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Progress in drug research 63 Chemotherapie swd Krebs <Medizin> swd Antineoplastic Agents therapeutic use Cancer Chemotherapy Drug Delivery Systems Drug targeting Neoplasms drug therapy Schultz, Richard M. Sonstige (DE-588)130400289 oth Progress in drug research 63 (DE-604)BV002528909 63 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Advances in targeted cancer therapy Progress in drug research Chemotherapie swd Krebs <Medizin> swd Antineoplastic Agents therapeutic use Cancer Chemotherapy Drug Delivery Systems Drug targeting Neoplasms drug therapy |
| title | Advances in targeted cancer therapy |
| title_auth | Advances in targeted cancer therapy |
| title_exact_search | Advances in targeted cancer therapy |
| title_full | Advances in targeted cancer therapy ed. by Richard M. Schultz |
| title_fullStr | Advances in targeted cancer therapy ed. by Richard M. Schultz |
| title_full_unstemmed | Advances in targeted cancer therapy ed. by Richard M. Schultz |
| title_short | Advances in targeted cancer therapy |
| title_sort | advances in targeted cancer therapy |
| topic | Chemotherapie swd Krebs <Medizin> swd Antineoplastic Agents therapeutic use Cancer Chemotherapy Drug Delivery Systems Drug targeting Neoplasms drug therapy |
| topic_facet | Chemotherapie Krebs <Medizin> Antineoplastic Agents therapeutic use Cancer Chemotherapy Drug Delivery Systems Drug targeting Neoplasms drug therapy |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013370934&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002528909 |
| work_keys_str_mv | AT schultzrichardm advancesintargetedcancertherapy |